Therapy of HES, PV, Atypical CML or CMML, and Mastocytosis With Imatinib Mesylate

This study is ongoing, but not recruiting participants.

Study NCT00038675 Information provided by M.D. Anderson Cancer Center

First Received: June 4, 2002 Last Updated: April 21, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2011
Estimated Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)